24 HR Levetiracetam 500 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Levetiracetam extended-release tablet is indicated for the treatment of partial-onset seizures in patients 12 years of age and older ( 1 ) Levetiracetam extended-release tablet is indicated for the treatment of partial-onset seizures in patients 12 years of age and older.

Lupin Pharmaceuticals, Inc.

FDA Reported Adverse Reactions
`[1] drug dependence` `[2] drug ineffective` `[3] pain` `[4] overdose` `[5] off label use` `[6] fatigue` `[7] rheumatoid arthritis` `[8] dyspnoea` `[9] nausea` `[10] emotional distress`

5 years ago

OVAL WHITE L008

5 years ago

L008 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

LEVETIRACETAM Extended-release Tablets USP, 500 mg are white to off white, oblong-shaped, biconvex, film coated tablets, imprinted 'L008' (in black ink) on one side and plain on the other side. They are supplied in white HDPE bottles containing 60 tablets (NDC 68180-117-07).

LEVETIRACETAM Extended-release Tablets USP, 750 mg are white to off white, oblong-shaped, biconvex, film coated tablets, imprinted 'L009' (in black ink) on one side and plain on the other side. They are supplied in white HDPE bottles containing 60 tablets (NDC 68180-118-07). 16.2 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Pharmacist: Dispense in a tight, light-resistant container with a child-resistant closure.

More pills like OVAL L008

Related Pills

24 HR Levetiracetam 750 MG Extended Release Oral Tablet

lupin pharmaceuticals, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site